Page 8 - Pfizer

Pfizer signs $5.3-bn deal with US govt for 10 mn Covid-19 pills

The oral drug could be a promising new weapon in the fight against the pandemic

FDA plans to authorise Pfizer boosters for adults this week: Report

The Food and Drug Administration is aiming to authorise booster doses of Pfizer-BioNTech's coronavirus vaccine for all adults as early as Thursday

Stocks to Watch: IndiGo, Biocon, Pfizer, IEX, TFCI, SAIL, BHEL, Nalco

Indian Energy Exchange and Apollo Pipes have announced their respective record dates for the issuance of bonus shares for eligible shareholders

Pfizer to allow generic versions of its Covid-19 pill in 95 countries

The voluntary licensing agreement between Pfizer and the MPP will allow the United Nations-backed group to grant sub-licenses to qualified generic drug manufacturers

Pfizer's anti-Covid pill can be made by Indian drug firms without royalties

Pharma major will waive royalties on sales in all countries covered by the MPP agreement apart from poor nations

Multiple near-term concerns trigger Divi's Laboratories' headache

Pfizer's oral Covid drug, weak sales of generics, and valuations may cap upsides

Pfizer agrees to let other companies make its Covid-19 pill

The move could make the treatment available to more than half of the world's population

Pfizer fights to control secret of $36-billion Covid-19 jab recipe

Pfizer has begun to ramp up vaccine deliveries quickly outside the richest nations

Pfizer, Astra shots generate more antibodies than natural infection: Study

People who receive the Pfizer or AstraZeneca COVID-19 vaccine have antibody levels significantly higher than those infected with the SARS-CoV-2 virus, according to a study

Pfizer's oral Covid-19 drug may hit revenues of Divi's Laboratories

Supply of Molnupiravir to Merck was a key near-term trigger for the stock

S&P 500 hits record on strong jobs report, Pfizer Covid-19 pill cheer

US job growth regains momentum Pfizer jumps after positive Covid-19 antiviral pill data

Pfizer develops Covid pill that cuts hospitalisations and deaths by 89%

A pill that could be taken at home at the first sign of symptoms is a crucial tool for taming the Covid-19 crisis globally, so long as it's widely available

Wall St extends record rally on strong jobs report, Pfizer Covid pill cheer

October payrolls surge back as virus impact fades; travel stocks lead broader market gains

Top headlines: Pfizer's pill cuts risk of severe Covid; Delhi AQI worsens

Business Standard brings you the top headlines on Friday

Pfizer Ltd net profit rises 9% to Rs 143 crore in September quarter

The drug firm on Wednesday reported an 8.81% rise in net profit

'Turning point': Pfizer vaccine gets final nod for children over five

CDC Director Rochelle Walensky recommended the vaccine for children from 5 to 11 years old

Stocks to Watch: SBI, Airtel, SpiceJet, Trent, Mtar, Pfizer, HPCL, Bata

SBI and other banking shares, along with stocks of companies to report earnings today will be in focus

US gives final clearance to Pfizer's Covid-19 shots for kids 5 to 11

The decision marks the first opportunity for Americans under 12 to get the powerful protection of any COVID-19 vaccine.

US CDC advisors recommend Pfizer's Covid-19 vaccine for children aged 5-11

The vaccine is one-third the adult dose and the it would be given in two doses, three weeks apart. The lower dose was chosen to minimize side effects and still produce strong immunity, said Pfizer.

Third Pfizer vax dose more effective in reducing severe Covid: Lancet

A third vaccine dose of Pfizer-BioNTech is effective in reducing severe Covid related outcomes compared to individuals who have received two vaccine doses at least five months ago, finds a new study.